Palmer et al., 2003 - Google Patents
Diagnosis of breast cancer using optical spectroscopyPalmer et al., 2003
- Document ID
- 1931586030300430906
- Author
- Palmer G
- Ramanujam N
- Publication year
- Publication venue
- Medical Laser Application
External Links
Snippet
Fluorescence and diffuse reflectance spectroscopy have shown great promise in diagnosing cancer at a number of organ sites, including the cervix, bronchus, and colon. Recent research has also found that similar techniques, when applied to the breast, can provide …
- 206010006187 Breast cancer 0 title abstract description 37
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/0059—Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Palmer et al. | Comparison of multiexcitation fluorescence and diffuse reflectance spectroscopy for the diagnosis of breast cancer (March 2003) | |
Palmer et al. | Autofluorescence Spectroscopy of Normal and Malignant Human Breast Cell Lines¶ | |
Liu et al. | Raman, fluorescence, and time-resolved light scattering as optical diagnostic techniques to separate diseased and normal biomedical media | |
Zhu et al. | Diagnosis of breast cancer using diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least squares analysis based feature extraction technique | |
Manoharan et al. | Raman spectroscopy and fluorescence photon migration for breast cancer diagnosis and imaging | |
Drezek et al. | Autofluorescence microscopy of fresh cervical‐tissue sections reveals alterations in tissue biochemistry with dysplasia¶ | |
Wang et al. | Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy | |
Richards‐Kortum et al. | Spectroscopic diagnosis of colonic dysplasia | |
Skala et al. | Investigation of fiber‐optic probe designs for optical spectroscopic diagnosis of epithelial pre‐cancers | |
Yong et al. | Distinction of brain tissue, low grade and high grade glioma with time-resolved fluorescence spectroscopy | |
Kalaivani et al. | Fluorescence spectra of blood components for breast cancer diagnosis | |
Alfano et al. | Optical biopsy for cancer detection | |
Mehidine et al. | Optical signatures derived from deep UV to NIR excitation discriminates healthy samples from low and high grades glioma | |
Wang et al. | Rapid, label-free, and highly sensitive detection of cervical cancer with fluorescence lifetime imaging microscopy | |
US6080584A (en) | Method and apparatus for detecting the presence of cancerous and precancerous cells in a smear using native fluorescence spectroscopy | |
Palmer et al. | Diagnosis of breast cancer using optical spectroscopy | |
CN106834511A (en) | A kind of kit of the breast cancer detection based on liquid biopsy | |
Sun et al. | Evaluation of autofluorescence visualization system in the delineation of oral squamous cell carcinoma surgical margins | |
Ebenezar et al. | Diagnostic potential of stokes shift spectroscopy of breast and prostate tissues—a preliminary pilot study | |
Mathieu et al. | Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses | |
Damayanti et al. | A hybrid FLIM-elastic net platform for label free profiling of breast cancer | |
Noble Anbunesan et al. | Intraoperative detection of IDH‐mutant glioma using fluorescence lifetime imaging | |
Alchab et al. | Towards an optical biopsy for the diagnosis of breast cancer in vivo by endogenous fluorescence spectroscopy | |
Chowdary et al. | Autofluorescence of breast tissues: evaluation of discriminating algorithms for diagnosis of normal, benign, and malignant conditions | |
Kanniyappan et al. | An in vitro diagnosis of oral premalignant lesion using time-resolved fluorescence spectroscopy under UV excitation—a pilot study |